Home / Health / Weight-Loss Drugs Linked to Hair Loss Risk
Weight-Loss Drugs Linked to Hair Loss Risk
4 Sep
Summary
- New study finds GLP-1 drugs may increase hair loss risk.
- Genetic link found between GLP-1 use and male-pattern baldness.
- Risk increase estimated at 7%, beyond rapid weight loss effects.
A recent study published in the Journal of Investigative Dermatology has uncovered a potential link between the use of GLP-1 medications, such as Ozempic and Wegovy, and an increased risk of hair loss.
Researchers at NYU Langone Health identified the first genetic evidence suggesting that GLP-1 receptor activity may contribute to androgenetic alopecia, the most common form of hair loss in men. This finding implies a biological connection beyond the known side effect of temporary shedding due to rapid weight loss.
The study analyzed genetic data from over 31,000 individuals and found a consistent 7 percent increased risk of hair loss associated with genetic markers for increased GLP-1 activity. This risk remained even after accounting for other factors like hypertension and insulin resistance.
While the findings are significant, experts advise against immediate discontinuation of these medications. They emphasize that the 7 percent risk increase is modest and the research used genetic data rather than prospective patient tracking. Future studies are planned to explore this connection further, potentially leading to preventative treatments for at-risk individuals.
